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562 Abstracts February 2014Carotid Artery Stenting May Be Performed Safely in Patients With
Radiation Therapy-Associated Carotid Stenosis Without Increased
Restenosis or Target Lesion Revascularization: Results of a
Multicenter Review
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Objectives: Neck radiation therapy (XRT) may induce carotid artery
atherosclerosis and may increase the technical difﬁculty of endarterectomy
(CEA). It is considered a relative indication for carotid angioplasty and
stenting (CAS). This study sought to evaluate differences in CAS embolic
potential and restenosis performed on XRT and non-XRT patients.
Methods: A total of 366 CAS procedures were performed on 321 pa-
tients (43 XRT and 323 non-XRT) at three institutions. Mean follow-up
was 410 days (median, 282 days; range, 3-1920 days). Patients were fol-
lowed up with duplex ultrasound imaging to assess for restenosis. Additional
end points included target lesion revascularization, myocardial and cerebro-
vascular events, and perioperative complications. Captured particulates from
embolic protection ﬁlters were analyzed using photomicroscopy and image
analysis software for 27 XRT and 214 non-XRT ﬁlters.
Results: XRT patient were more likely to be male and had lower rates
of hypertension, coronary artery disease, and diabetes mellitus, although the
mean age at procedure did not differ (Table). There was a trend toward
increased severe internal carotid tortuosity among XRT patients (XRT: 50%
vs non-XRT: 34.7%; P ¼ .05). Indication for CAS did not differ between
the two groups, including the number of CAS performed for symptomatic
carotid stenosis (XRT: 39.7% vs non-XRT: 39.0%; P ¼ not signiﬁcant
[NS]). Perioperative outcomes, including the composite of 30-day stroke/
myocardial infarction/mortality were not signiﬁcantly different (XRT: 2.6%
vs non-XRT: 3.9%; P ¼ NS.) There were no signiﬁcant differences in the
restenosis rate at the 50% (XRT: 9.4% vs non-XRT: 8.6%; P ¼ NS) or 70%
(XRT: 3.5% vs non-XRT: 8.6%; P ¼ NS) threshold. Filter particle analysis
revealed that ﬁlters from XRT patients had more numerous large particles
per ﬁlter and larger particles (Table). Target lesion revascularization did not
differ signiﬁcantly between the groups.
Conclusions: In contrast to earlier studies, this analysis reveals that
there are signiﬁcant differences in XRT and non-XRT patients undergoing
CAS in terms of medical comorbidities, anatomy, and embolic potential.
A decreased incidence of atherosclerotic risk factors was observed in XRT
patients, likely because XRT was the primary factor responsible for carotid
stenosis. Despite increased tortuosity and embolic particle size, CAS can
be performed safely with no increased morbidity, target lesion revasculariza-
tion, or restenosis in XRT patients.
Table. Demographics and particulate data (P values by c2 and t-test)
Variable XRT Non-XRT PMean age, years 68.9 71.1 NS
Male, No. (%) 34 (79) 183 (56.7) <.01
Hypertension, No. (%) 26 (63.4) 292 (90.6) <.0001
Coronary artery disease, No. (%) 15 (36.5) 192 (59.6) <.05
Diabetes mellitus, No. (%) 8 (19.5) 117 (36.3) <.05
Particulate data
Mean maximum particle size/ﬁlter, mm 1.4 0.74 <.05
Mean maximum particle size/ﬁlter, mm 1504.5 307.8 <.01Upper Extremity Blood Pressure Differential Strongly Predicts
Cerebrovascular Disease and Carotid Artery Stenosis
Karan Garg, MD, Jeffrey S. Berger, MD, Yu Guo, MS, Mark A.
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Objectives: An upper extremity (UE) systolic blood pressure (SBP)
differential has been reported to be a marker for systemic atherosclerosis.
However, the relationship between the degree of SBP differential and the
prevalence of cerebrovascular disease has not been speciﬁcally deﬁned.
The goal of this study was to analyze a large cohort of patients who under-
went vascular screening tests and to determine the relationship between an
UE SBP differential, clinical cerebrovascular disease, and carotid artery
stenosis.Methods: Of 3,696,778 patient screened, 241,959 did not have both
UE SBP recorded, and were excluded. The remaining subjects were charac-
terized as having no signiﬁcant SBP difference (<10 mm Hg differential),
mild (11-15 mm Hg), moderate (16-20 mm Hg), and severe ($20 mm
Hg) differences. Standard statistical analysis was performed.
Results: Of 3,454,819 subjects, 86.8% had no signiﬁcant UE SBP dif-
ferential, 9.1% (313,352) had a mild difference, 3.9% (134,278) had a mod-
erate difference, and 0.2% (7657) had a severe difference. Increasing degrees
of UE SBP differential were directly and signiﬁcantly associated with
increased age, tobacco use, hypertension, hypercholesterolemia, diabetes,
and obesity (P < .001). Increasing degrees of UE SBP differential were
directly and signiﬁcantly associated with a history of stroke and a history
of transient ischemic attack. Increasing degrees of UE SBP differential
were directly and signiﬁcantly associated with both moderate ($50%) and
severe ($80%) carotid artery stenosis (P < .001; Fig). In multivariate
analysis, an UE SBP difference of $15 mm Hg was an independent pre-
dictor of carotid artery stenosis (odds ratio, 1.3); a differential of >20 mm
Hg nearly quadrupled the risk of having signiﬁcant carotid artery disease
(odds ratio, 3.9).
Conclusions: Subjects with UE SBP differentials are more likely to
have traditional atherosclerotic risk factors. However, even after adjusting
for these risk factors, an UE SBP difference is an independent risk factor
for cerebrovascular disease. SBP differentials noted in the upper extremities
can be potentially used as an excellent screening marker for the presence of
extracranial cerebrovascular disease.
Fig. BP difference and incidence of cerebrovascular disease.
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Objectives: The purpose of the study was to assess predictors of long-
term disease progression and clinical outcomes after carotid endarterectomy
(CEA) in contemporary practice.
Methods: A consecutive cohort of CEAs between January 1, 2000,
and December 31, 2010, was retrospectively analyzed. End points were
restenosis $50% and $70%, contralateral carotid disease progression
(50%-69%, 70%-99%, or occlusion), and stroke. Survival analysis and Cox
regression models were used to assess the effect of baseline predictors.
Results: A total of 1782 CEAs (bilateral, 142; mean age, 71.4 6 9.3
years; 56.3% male; 35.4% symptomatic, 2.7% combined with coronary artery
bypass grafting) were performed during the study period with a mean clin-
ical follow-up of 54.8 months (range, 1-155 months). Periprocedural stroke
and death rates were 1.9% and 0.8%, respectively (stroke/death: overall,
2.6%; asymptomatic cohort, 1.8%). Freedom from restenosis and contralat-
eral carotid stenosis progression is shown in the Fig, both events attaining
higher rates of critical values ($70%) after 5 years. Thirty-one (20.4%)
restenosis were symptomatic (5 at $50%, 26 at $70%), and 40 (26.3%)
underwent reintervention. Restenosis was predicted by hypertension (HR,
2.06; P ¼ .031), female gender (HR, 1.54; P ¼ .012), and younger age
#65 years (HR, 1.64; P ¼ .009). Contralateral progression was predicted
by smoking (HR, 1.85; P ¼ .007) and renal insufﬁciency (HR, 2.40; P ¼
.001), resulting in carotid intervention in 27.1% of patients. No association
was shown with either closure technique (primary vs patch vs eversion) or
statins. Any stroke (118 events: 68 ipsilateral, 49 contralateral) rates at 5 and
10 years were 7.2% and 14.9%, respectively. Predictors were symptomatic
indication (HR, 1.51; P ¼ .033), renal insufﬁciency (HR, 1.58; P ¼ .046),
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referable to contralateral progression was 5.6% (6 of 107).
Conclusions: Restenosis and contralateral carotid stenosis after CEA
progress signiﬁcantly after 5 years, with possible impact on surveillance stra-
tegies. Restenosis was not associated with closure technique. Statin use re-
duces new symptoms but not the rate of disease progression.
Fig. Freedom from restenosis and contralateral progression of
ICA stenosis following CEA.
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Objectives: Carotid endarterectomy (CEA) is currently performed by
various surgical specialties with varying outcomes. This study analyzes
different surgical practice patterns and their impact on perioperative stroke
and cost.
Methods: This is a retrospective analysis of prospectively collected
data of 1000 consecutive CEAs performed at our institution by three
different specialties: general surgeons (GS), cardiothoracic surgeons (CT),
and vascular surgeons (VS).
Results: A total of 474 CEAs were done by VS, 404 by CT, and
122 by GS.VS tended to operate more often on symptomatic patients
than CT and GS: 40% vs 23% and 31%, respectively (P < .0001). Preop-
erative workups were signiﬁcantly different between specialties: duplex ul-
trasound (DUS) only in 66%, 30%, and 18%; DUS and CTA in 27%, 35%,
and 29%; DUS and MRA in 6%, 35%, and 52% for VS, CT, and GS,
respectively (P < .001). The mean preoperative carotid stenosis was not
signiﬁcantly different between the specialties. The mean heparin dosage
was 5168, 7522, and 5331 units (P ¼ .0001), and protamine was used
in 0.2%, 19%, and 8% (P < .0001) for VS, CT, and GS, respectively. Post-
operative drains were used more often by VS; however, there was no as-
sociation between heparin dosage, protamine, and drain use and
postoperative bleeding. Patching was used in 99%, 93%, and 76% (P <
.0001) for VS, CT, and GS. Bovine pericardial patches were used more
often by CT, and ACUSEAL (Gore) patches were used more often by
VS (P < .0001). The perioperative stroke/death rates were 1.27% for
VS and 3.04% for CT and GS combined (P ¼ .055); and for asymptom-
atic patients, 0.7% for VS and 3.02% for CT and GS combined (P < .034).
Perioperative stroke rates for patients who had preoperative DUS only
were 0.88% vs 3.29% for patients who had extra imaging (computed to-
mography/magnetic resonance angiography; P ¼ .009); and for asymp-
tomatic patients, it was 0.94% vs 3.01% (P ¼ .05). When applying
hospital billing charges for preoperative imaging workups (cost of DUS
only vs DUS and other imaging), the VS practice pattern would have
saved $1180 per CEA over CT and GS practice patterns; a total savings
of $1,180,000 in this series.
Conclusions: CEA practice patterns differ between specialties.
Although the cost was higher for non-VS practices, the perioperative
stroke/death rate was somewhat higher. Therefore, educating physicians
who perform CEAs on cost-saving measures may be appropriate.A Propensity Score Matched Analysis of Asymptomatic Patients
Undergoing Carotid Endarterectomy (CEA) vs Coronary Artery
Bypass Graft (CABG) vs Combined CEA-CABG in the ACS-NSQIP
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Objectives: Carotid endarterectomy (CEA) and coronary artery
bypass grafting (CABG) may be combined to treat concomitant coronary
artery and carotid artery atherosclerotic disease. Previous reports on com-
bined CEA/CABG have shown wide variation in adverse event rates for
asymptomatic patients and have often been limited by small sample size
or lack of granularity, or both. We aim to compare stroke and death after
CEA/CABG with CEA or CABG alone in asymptomatic patients by using
the American College of Surgeons (ACS) National Surgical Quality
Improvement Program (NSQIP) database.
Methods: All patients undergoing CEA, CABG, or CEA/CABG
from 2005 to 2011 in the NSQIP database were identiﬁed. NSQIP-docu-
mented neurologic symptoms lack laterality and temporal detail for assign-
ment of positive current neurologic symptoms, whereas asymptomatic
patients are captured with excellent accuracy. Accordingly, only asymptom-
atic patients were analyzed. Propensity score matched groups of asymptom-
atic patients were based on age, sex, and American Society of
Anesthesiologists class 4. Analysis of variance, c2, and multivariable logistic
regression were used to compare stroke, death, and combined stroke/death
across procedures.
Results: We identiﬁed 47,667 patients: 42,474 CEA (89%), 5018
CABG (11%), and 175 CEA/CABG (<1%). Forty percent of all patients
had a history of neurologic symptoms and were omitted from consideration:
43% CEA, 12% CABG, and 28% CEA-CABG. Unmatched rates of stroke/
death in asymptomatic patients were 1.4% (CEA), 3.3% (CABG), and 6.7%
(CEA/CABG). Propensity score matching identiﬁed 1332 asymptomatic
patients: 606 CEA, 607 CABG, and 119 CEA/CABG. Stroke, death,
and stroke/death rates are compared across procedures in the Table. In-
dependent risk factors for stroke/death among matched asymptomatic
patients were recent myocardial infarction (odds ratio [OR], 4.0; 95%
conﬁdence interval [CI], 2.0-8.0), COPD (OR, 4.7l; 95% CI, 2.4-9.2), and
age >70 years (OR, 2.7; 95% CI, 1.4-5.2). CEA/CABG compared with
CABG alone did not have increased risk of stroke/death (OR, 6; 95% CI,
0.2-1.4). No signiﬁcant difference was seen between the stroke/death rate
of CEA/CABG (6.7%) compared with the aggregate of CEA and CABG
alone (2.1% + 4.2%).
Conclusions: In asymptomatic patients, CEA/CABG does not
confer an increased risk for stroke/death compared with the combined
risk of CEA and CABG alone. CEA/CABG should be considered a safe
approach in asymptomatic patients requiring CEA and CABG.
Table. Propensity score matched group outcome comparison
CEA CABG CEA-CABG PVariable (n ¼ 606) (n ¼ 607) (n ¼ 119) (CABG vs CEA/CABG)Death, % 1.2 2.3 3.4 .516
Stroke, % 1.2 2.0 3.4 .314
Stroke/
death, %
2.1 4.1 6.7 .227Axillary-Axillary Arteriovenous PTFE Grafts for Hemodialysis in
Difﬁcult Patients
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Objectives: Long-term hemodialysis patients are a difﬁcult patient
population because they have few remaining access options and may have
disadvantaged vasculature in the upper extremities. Because of the increased
infection rate with femoral access, surgeons may place an axillary artery-to-
axillary vein arteriovenous graft (AAAVg). Few outcome reports of this
technique exist. In this study, which is the largest reported to date, we inves-
tigate the results of the AAAVg conﬁguration.
Methods: At our institution, an AAAVg is a polytetraﬂuoroethylene
(PTFE) graft in a loop conﬁguration in the upper chest with anastomoses
to the axillary artery and ipsilateral axillary vein. After Investigational Review
